Polycarbonate Chemical Compatibility Overview
This overview shows the chemical resistancy of Lexan polycarbonate sheet. Chemical compatibility of thermoplastics e.g. Lexan is
dependent on contact time, temperature and stress (external stress to which the application is subjected).
Chemical exposure can result in discoloration, softening, swelling, crazing, cracking or loss of properties of the thermoplastic.
The chemicals listed have been evaluated for Lexan according a very stringent GE-test method. This test incorporates exposure to
the chemical under defined conditions including temperature (20 and 80 C) and stress (0.5 and 1% strain) for a time period of seven
days. The results are listed in the overview using symbols (+ or 0 or -) which are explained below.
This information should be used as indicative only. The true chemical compatibility can only be determined under conditions as in
the final application. Please contact your local representative in case additional information is required.
Metal & Metal Oxide
Poor; Not recommended-will result in failure or severe degradation.
Fair; Found marginal-only for short exposures at lower temperatures or when loss of properties is not critical.
Good; Found unaffected in its performance when exposed with regards to time, temperature and stress according
the GE-test method.
All information, recommendation or advice contained in this document or given by
General Electric Company*, USA, or any of its subsidiaries, affiliates or authorised
representatives, whether written or oral, is given in good faith, to the best of its
knowledge and based on current procedures in effect. The products of General Electric
Company or, if applicable, of its subsidiaries or affiliates are sold subject to Conditions of
Sale, printed on the back of order acknowledgements, invoice or available upon request.
Nothing in this or any other document shall after, vary, supersede or separate to waive
any of the Conditions of Sale. Each user of the products shall convince himself, through
all available sources (including finished product testing in its appropriate environment) of
the suitability of the products supplied for its own particular purpose. Because actual use
of the products by the user is beyond the control of General Electric Company, its
subsidiaries and affiliates, such use is within the exclusive responsibility of the user.
General Electric Company, its subsidiaries and affiliates cannot be held responsible for
any loss incurred through incorrect or faulty use of the products. Information,
recommendation and/or advice are neither made to infringe on any patents, nor to grant a
license under any patent or intellectual property right of General Electric Company or any
of its subsidiaries or affiliated companies, nor to grant the right to file for any patent
*Company not connected with the English company of a similar name.
Minutes of Planning Advisory Committee meeting held on the above date in the Town Council Chambers at 5:30 p.m. Chairman Ken Johnston presided. PRESENT: Mayor Joe Hawes, Councillors Raymond Gregory, Bob Naylor Committee members: Mishi Babinec, Elwin Hemphill, Gary Nowlan, Tony Zuethoff Jeffrey Turnbull, Planner, PCDPC; Scott Conrod, CAO; Penny MacKenzie, Administrative Assistant; Stewart DeSoll
Medline Abstracts: J Foot Ankle Surg. 2005 Mar-Apr;44(2):137-43. Evaluation of ultrasound-guided extracorporeal shock wave therapy (ESWT) in the treatment of chronic plantar fasciitis. Hyer CF, Vancourt R, Block A. Orthopedic Foot and Ankle Surgery, Orthopedic Foot and Ankle Center, Columbus, Ohio, USA. Thirty patients (39 heels) were evaluated to determine the success of ultrasound-gu
Copyright © 2010 Health Drug Pdf